Prostate cancer can grow slowly and pose little threat to patients, or it can metastasize quickly, causing severe pain and death. But as of now, it's nearly impossible to determine which type of cancer a patient has during ...
Apr 2, 2019
0
12
There is insufficient evidence to underpin the use of tumour markers to detect the recurrence of testicular cancer in patients who have undergone surgery for an initial tumour, finds research from Oxford University published ...
Mar 27, 2019
0
6
According to the latest GLOBOCAN cancer database, New Zealand's breast cancer incidence rate is among the highest in the world. It affects one in nine women in their lifetime and accounts for almost half of all cancers for ...
Mar 1, 2019
0
24
A multi-center study led by researchers at The University of Texas MD Anderson Cancer Center revealed that a liquid biopsy test called Guardant360, is comparable to standard tissue biopsies in detection of guideline recommended ...
Feb 27, 2019
1
3
As new technology allows researchers to plunge deeper into the genome and exome, a new class of RNA called circular RNA may play an intriguing role.
Feb 7, 2019
0
46
Over 90 percent of malign tumours in the head and neck are originated from carcinomas of squamous cells that appear in superficial areas of the oral cavity. Their detection with salivary biomarkers can contribute to early ...
Nov 15, 2018
0
2
The most aggressive type of prostate cancer, castration-resistant prostate cancer, can be treated via two therapies: taxanes or hormone treatment. Until recently, there were no comparative studies between the two, and the ...
Nov 14, 2018
0
6
Scientists led by Dr. Daniel De Carvalho at Princess Margaret Cancer Centre have discovered a gene signature biomarker that may predict which patients will respond—or not—to immune therapy.
Nov 8, 2018
0
60
The human immune system is actually quite good at killing cancer cells. In fact, we believe it does so quite frequently. People who have AIDS or have had an organ transplant have suppressed immune systems and go on to develop ...
Sep 17, 2018
0
0
(HealthDay)—Biomarker-based risk profiling has the potential to improve lung cancer risk assessment, according to a study published online July 12 in JAMA Oncology.
Aug 6, 2018
0
2
